Table 3. Mixed model analysis by using time taken to reach minimum regional volume as dependent variable.
| ALL (n = 138) | Patients without LGE (n = 88) | Patients with QRS <120 ms (n = 117) | ||||
|---|---|---|---|---|---|---|
| Age | 1.87 (0.61~3.13) | 0.004 | 1.82 (0.53~3.11) | 0.006 | 1.26 (0.32~2.21) | 0.009 |
| Sex (M vs. F) | 8.07 (−21.41~37.58) | 0.588 | 2.07 (−25.43~29.57) | 0.881 | −2.51 (−25.65~20.64) | 0.830 |
| LGE | 6.02 (−67.82~79.87) | 0.873 | N/A | N/A | 5.55 (−59.14~70.25) | 0.866 |
| QRS >120 ms | 18.70 (−17.84~55.25) | 0.313 | 9.98 (−31.36~51.32) | 0.632 | N/A | N/A |
| Diabetes mellitus | −15.17 (−42.91~12.56) | 0.281 | 6.51 (−20.51~33.54) | 0.632 | −4.03 (−25.26~17.21) | 0.708 |
| Hypertension | 15.61 (−14.71~45.92) | 0.310 | −10.15 (−44.38~24.09) | 0.556 | −3.59 (−28.27~21.09) | 0.774 |
| CAD | 11.32 (−16.81~39.45) | 0.427 | 3.84 (−24.57~32.24) | 0.788 | −6.91 (−29.11~15.29) | 0.538 |
| LV mass index | 0.07 (−0.61~0.47) | 0.793 | 0.45 (−0.12~1.02) | 0.117 | 0.03 (−0.47~0.41) | 0.888 |
| Group | ||||||
| SHF vs. Control | 4.00 (−46.83~54.82) | 0.876 | 40.89 (−13.28~95.06) | 0.137 | 14.02 (−24.32~52.35) | 0.470 |
| HFpEF vs. Control | 18.55 (−20.60~59.69) | 0.369 | 18.95 (−11.16~49.06) | 0.213 | 11.02 (−16.79~38.83) | 0.433 |
| ECV | 3.77 (2.72~4.81) | <0.001 | 3.56 (1.75~5.37) | <0.001 | 3.76 (2.64~4.89) | <0.001 |
| LGE x ECV | 8.45 (−219.62~236.53) | 0.942 | N/A | 7.51 (−205.69~220.71) | 0.945 | |
Abbreviations: LGE, late gadolinium enhancement; CAD, coronary artery disease; SHF, systolic heart failure; HFpEF, heart failure with preserved ejection fraction; ECV, extracellular volume.